Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
Purpose Dupilumab is a widely recommended treatment for moderate-to-severe atopic dermatitis (AD), with known ocular side effects but less frequent cutaneous reactions.Material and methods This case report details a 52-year-old female patient with atopic dermatitis treated with dupilumab. After an i...
Saved in:
Main Authors: | C. Grote, F. Zirkenbach, J. N. Wagner, M. Augustin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2452987 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
by: Nicola Lutzu, et al.
Published: (2025-01-01) -
Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
by: Hila Emmert, et al.
Published: (2025-01-01) -
Demographic and clinical features of rosacea in North Jordan: a 10-year university hospital retrospective study
by: Diala Alshiyab, et al.
Published: (2025-12-01) -
Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01) -
A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries
by: Amani Alfalasi, et al.
Published: (2025-12-01)